Renaissance Technologies’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-485,500
| Closed | -$13.1M | – | 3986 |
|
|
2024
Q2 | $13.1M | Buy |
485,500
+60,900
| +14% | +$1.27M | 0.02% | 780 |
|
|
2024
Q1 | $7.78M | Buy |
424,600
+258,300
| +155% | +$4.1M | 0.01% | 1139 |
|
|
2023
Q4 | $2.04M | Sell |
166,300
-41,300
| -20% | -$387K | ﹤0.01% | 1941 |
|
|
2023
Q3 | $3.11M | Sell |
207,600
-131,600
| -39% | -$2.74M | 0.01% | 1584 |
|
|
2023
Q2 | $11M | Sell |
339,200
-154,400
| -31% | -$5.64M | 0.02% | 972 |
|
|
2023
Q1 | $19.3M | Buy |
493,600
+336,200
| +214% | +$16.4M | 0.03% | 736 |
|
|
2022
Q4 | $8.32M | Buy |
+157,400
| New | +$7.67M | 0.01% | 1199 |
|
|
2021
Q4 | – | Sell |
-50,492
| Closed | -$2.78M | – | 4299 |
|
|
2021
Q3 | $2.78M | Buy |
50,492
+13,092
| +35% | +$685K | ﹤0.01% | 1851 |
|
|
2021
Q2 | $1.79M | Sell |
37,400
-14,800
| -28% | -$754K | ﹤0.01% | 2331 |
|
|
2021
Q1 | $2.64M | Buy |
52,200
+23,700
| +83% | +$1.32M | ﹤0.01% | 2039 |
|
|
2020
Q4 | $1.79M | Sell |
28,500
-50,400
| -64% | -$3.13M | ﹤0.01% | 2181 |
|
|
2020
Q3 | $5.3M | Sell |
78,900
-29,400
| -27% | -$1.6M | 0.01% | 1543 |
|
|
2020
Q2 | $4.54M | Buy |
108,300
+90,200
| +498% | +$3.46M | ﹤0.01% | 1705 |
|
|
2020
Q1 | $570K | Buy |
+18,100
| New | +$725K | ﹤0.01% | 2694 |
|
Other funds holding SILK
Renaissance Technologies's SILK Position: Q3 2024 in Review
Renaissance Technologies sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 485,500 shares — an estimated $13.1M sold.
Renaissance Technologies first reported a position in SILK in Q1 2020 and held it in 14 quarters. The position peaked at $19.3M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Renaissance Technologies reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Renaissance Technologies sold 485,500 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $13.1M.
- Renaissance Technologies first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
- Renaissance Technologies's Silk Road Medical, Inc. Common Stock position peaked at $19.3M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.